Rodeo
Get started

DecenTrialz

RECANA OUS - Recana Thrombectomy Catheter System For Venous Obstruction And Occlusion Study RECANA-OUS-UK

London
Posted 26 days ago
Sign up to applySee more jobs like this

How your CV stacks up

1Upload CV
2Analyse CV
3Improve CV

Upload your CV to see how well it fits this job role

?%

Actively Recruiting

Phase Not Applicable

Age: 18 Years +

All Genders

ID: 07219758

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)

Led by Intervene, Inc.

Updated on 2026-05-06

30 Participants Needed

1 Research Site

N/A Total Duration

On this page

  • AI-Summary
  • Brief Title
  • Who Can Participate
  • AI-Screening
  • Your Study Journey
  • Trial Site Locations
  • Research Team
  • How is the study designed?
  • Similar Trials
  • Frequently Asked Questions

AI-Summary

What This Trial Is About

Researchers are evaluating the Recana Thrombectomy Catheter System to treat chronic venous obstruction and occlusion in people with symptomatic post-thrombotic venous inflow or outflow obstruction. This prospective, non-randomized study aims to assess the safety and performance of the device. The main questions are to understand the rates of adverse events within 30 days after the procedure and to measure if the treated vein achieves at least 50% opening during the procedure, using intravascular ultrasound. Participants who qualify will receive treatment with the Recana Thrombectomy Catheter System, which is designed to reopen and clear blockages in veins, both with and without stents. After the initial treatment procedure, participants will be followed and assessed at 30, 90, 180, and 365 days. The study includes clinical assessments, duplex ultrasound imaging, quality of life evaluations, monitoring of adverse events, and recording of any medications taken. Participants will be screened and evaluated before treatment to confirm eligibility. Safety and treatment effects are monitored closely from the day of the procedure through one year afterward. Follow-up visits include ultrasound scans and clinical exams to measure vein opening and check for any complications. The study aims to enroll patients over about 6 to 9 months, with total participation lasting around 18 to 21 months including follow-up.

Reasons to use Rodeo

I’m in my final year doing Economics and I don’t know whether to apply for grad schemes now or do a masters first. What do you think?

Honest answer — it depends on where you want to end up. A lot of top grad schemes (Big 4, civil service, banking) don’t need a masters. Let’s look at the ones you’d be competitive for now, and we can decide if a masters actually adds anything.

Also worth knowing: most autumn 2026 applications are open now. Timing matters more than you think.

Start with a chat, not a search bar

Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.

P

Graduate Consultant — 2026 Scheme

PwC·London, UK
£35,000/yr

Why you're a good match

Strong

Your economics background and your summer at a regional bank line up with what PwC looks for on the consulting scheme. Applications close in four weeks.

See breakdown
Save jobNot relevant
View details

It searches the market for you

Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.

Why you're a good match

You’ve got the grades and the economics background, and your bank internship is exactly the experience this scheme looks for. Apply soon — deadlines close within the month.

See breakdown
Strong

Experience fit

Your summer at the bank plus your econometrics coursework map directly to the day-one responsibilities on this scheme — client modelling, market briefings, and deal support.

See breakdown
Strong

Only hits

No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.

CONDITIONS

Brief Title

RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)

Who Can Participate

Age: 18 Years +

All Genders

Eligibility Criteria

You may qualify if you...

  • Signed and dated informed consent form
  • Age 18 years or older
  • Neurologically stable
  • Able to walk (ambulatory)
  • Symptomatic chronic venous disease with edema or pain (CEAP classification C3 or higher)
  • Flow-limiting venous outflow obstruction (>50%) in target sites as defined by ultrasound or imaging
  • Target area for treatment from IVC/Common Iliac confluence to deep veins above the knee

You will not qualify if you...

  • Limited life expectancy less than 2 years or comorbidities that increase risk
  • Invasive abdominal, pelvic, or peripheral vascular surgery within 90 days before procedure
  • Stroke within the last 6 months
  • Known hypercoagulable conditions that cannot be managed, including Heparin-induced thrombocytopenia and antiphospholipid syndrome
  • Interventional procedure in the deep venous system within 6 weeks prior to consent
  • Acute deep venous thrombosis in the limb within 3 months prior to consent
  • Inadequate inflow or untreatable flow-limiting obstruction central to target vessel
  • Pregnant or breastfeeding
  • Cognitive impairments preventing consent
  • Enrolled in another conflicting clinical study
  • COPD or similar lung conditions increasing pulmonary risk
  • Vulnerable populations
  • Inability to access veins or cross lesion for treatment

AI-Screening

Get help with your application

Your very own career expert that helps elevate your application to the next level.

Get help applying for this job

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

  1. First name *
  2. Last name *
  3. Email Address *
  4. Phone Number *
  5. +1
  6. Gender *
  7. ZIP Code *
  8. I agree to receive SMS messages from DecenTrialz regarding trial matching, appointment updates, participant updates, and related information. Message frequency varies. Message & data rates may apply. Reply STOP to cancel or HELP for assistance. I also agree to the Terms of Service and Privacy Policy.*

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

  • 1 visit (in-person) for informed consent and eligibility assessments

Implementation

Duration - Day of the index procedure through hospital discharge

Participants undergo the index procedure where the Recana Thrombectomy Catheter System is used to treat symptomatic post-thrombotic venous inflow/outflow obstruction.

  • 1 visit for the procedure and hospital stay

Follow-up

Duration - 365 days post-procedure

Participants are monitored for safety and efficacy through clinical assessments, duplex ultrasound, quality of life evaluations, and adverse event tracking.

  • Visits at 30, 90, 180, and 365 days post-procedure

Trial Site Locations

Total: 1 location

St. Thomas' Hospital

London, United Kingdom, SE1 7EH

Actively Recruiting

Loading map...

Research Team

Clinical Affairs Team

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.

Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

How is the study designed?

Similar Trials

Frequently Asked Questions

Sponsors

Intervene, Inc.

Lead Sponsor

Trusted by 25,000+ job seekers

“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”

Jessica, London

Get help applying for this job

Skills

Clinical Research
Patient Screening
Data Collection
Patient Monitoring
Clinical Assessment
Ultrasound Imaging

Location

London, England, United Kingdom

Sign up to applySee more jobs like this